154 related articles for article (PubMed ID: 31736256)
1. Are population-based patient-reported outcomes associated with overall survival in patients with advanced pancreatic cancer?
Dai WF; Beca J; Guo H; Isaranawatchai W; Schwartz D; Naipaul R; Arias J; Qiao Y; Gavura S; Redmond-Misner R; Ismail Z; Barbera L; Chan K
Cancer Med; 2020 Jan; 9(1):215-224. PubMed ID: 31736256
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Baseline Edmonton Symptom Assessment Scale Scores on Treatment and Survival in Patients With Advanced Non-small-cell Lung Cancer.
McGee SF; Zhang T; Jonker H; Laurie SA; Goss G; Nicholas G; Albaimani K; Wheatley-Price P
Clin Lung Cancer; 2018 Jan; 19(1):e91-e99. PubMed ID: 28666762
[TBL] [Abstract][Full Text] [Related]
3. Integrating Patient-Reported Outcomes Into Prognostication in Gastroesophageal Cancer: Results of a Population-Based Retrospective Cohort Analysis.
Baccili Cury Megid T; Sharma D; Baskurt Z; Xiaolu Ma L; Wang X; Barron CC; Jang RW; Chen EX; Swallow CJ; Mesci A; Yeung J; Wong RKS; Brar SS; Veit-Haibach P; Kim J; Bach Y; Aoyama H; Elimova E
Oncologist; 2024 Apr; 29(4):316-323. PubMed ID: 38431782
[TBL] [Abstract][Full Text] [Related]
4. The impact of routine Edmonton Symptom Assessment System (ESAS) use on overall survival in cancer patients: Results of a population-based retrospective matched cohort analysis.
Barbera L; Sutradhar R; Seow H; Mittmann N; Howell D; Earle CC; Li Q; Thiruchelvam D
Cancer Med; 2020 Oct; 9(19):7107-7115. PubMed ID: 32794634
[TBL] [Abstract][Full Text] [Related]
5. Patient-Reported Symptoms for Esophageal Cancer Patients Undergoing Curative Intent Treatment.
Gupta V; Allen-Ayodabo C; Davis L; Zhao H; Hallet J; Mahar AL; Ringash J; Kidane B; Darling G; Coburn NG
Ann Thorac Surg; 2020 Feb; 109(2):367-374. PubMed ID: 31550465
[TBL] [Abstract][Full Text] [Related]
6. Symptom Burden of Patients with Advanced Pancreas Cancer (APC): A Provincial Cancer Institute Observational Study.
Lelond S; Ward J; Lambert PJ; Kim CA
Curr Oncol; 2021 Jul; 28(4):2789-2800. PubMed ID: 34436010
[TBL] [Abstract][Full Text] [Related]
7. Utility of the revised Edmonton Symptom Assessment System (ESAS-r) and the Patient-Reported Functional Status (PRFS) in lung cancer patients.
Yogananda MN; Muthu V; Prasad KT; Kohli A; Behera D; Singh N
Support Care Cancer; 2018 Mar; 26(3):767-775. PubMed ID: 29027005
[TBL] [Abstract][Full Text] [Related]
8. Symptom Burden in Patients With Reduced Performance Status at the Start of Palliative Radiotherapy.
Nieder C; Kämpe TA
In Vivo; 2020; 34(2):735-738. PubMed ID: 32111778
[TBL] [Abstract][Full Text] [Related]
9. Association Between Preoperative Patient-Reported Symptoms and Postoperative Outcomes in Rectal Cancer Patients: A Retrospective Cohort Study.
Bubis LD; Coburn NG; Sutradhar R; Gupta V; Jeong Y; Davis LE; Mahar AL; Karanicolas PJ
J Surg Res; 2021 Mar; 259():86-96. PubMed ID: 33279848
[TBL] [Abstract][Full Text] [Related]
10. Province-Wide Analysis of Patient-Reported Outcomes for Stage IV Non-Small Cell Lung Cancer.
Tjong MC; Doherty M; Tan H; Chan WC; Zhao H; Hallet J; Darling G; Kidane B; Wright FC; Mahar A; Davis LE; Delibasic V; Parmar A; Mittmann N; Coburn NG; Louie AV
Oncologist; 2021 Oct; 26(10):e1800-e1811. PubMed ID: 34216415
[TBL] [Abstract][Full Text] [Related]
11. Oncology Nurses' Attitudes Toward the Edmonton Symptom Assessment System: Results From a Large Cancer Care Ontario Study.
Green E; Yuen D; Chasen M; Amernic H; Shabestari O; Brundage M; Krzyzanowska MK; Klinger C; Ismail Z; Pereira J
Oncol Nurs Forum; 2017 Jan; 44(1):116-125. PubMed ID: 27991609
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with patient-reported subjective well-being among advanced lung or non-colonic gastrointestinal cancer patients.
Yennurajalingam S; Kim YJ; Zhang Y; Park J; Arthur J; Chisholm GB; Williams JL; Bruera E
Palliat Support Care; 2018 Feb; 16(1):23-31. PubMed ID: 28264748
[TBL] [Abstract][Full Text] [Related]
13. The impact of automated screening with Edmonton Symptom Assessment System (ESAS) on health-related quality of life, supportive care needs, and patient satisfaction with care in 268 ambulatory cancer patients.
Diplock BD; McGarragle KMC; Mueller WA; Haddad S; Ehrlich R; Yoon DA; Cao X; Al-Allaq Y; Karanicolas P; Fitch MI; Myers J; Mitchell AJ; Ellis JWM
Support Care Cancer; 2019 Jan; 27(1):209-218. PubMed ID: 29931490
[TBL] [Abstract][Full Text] [Related]
14. Pre-screening of patient-reported symptoms using the Edmonton Symptom Assessment System in outpatient palliative cancer care.
Lee G; Kim HS; Lee SW; Park YR; Kim EH; Lee B; Hu YJ; Kim KA; Kim D; Cho HY; Kang B; Choi HJ
Eur J Cancer Care (Engl); 2020 Nov; 29(6):e13305. PubMed ID: 33016473
[TBL] [Abstract][Full Text] [Related]
15. Symptom Burden of Nonresected Pancreatic Adenocarcinoma: An Analysis of 10,753 Patient-Reported Outcome Assessments.
Mavros MN; Davis LE; Hallet J; Tung S; Mahar AL; Bubis LD; Hammad A; Zhao H; Earle CC; Barbera L; Coburn NG
Pancreas; 2020 Sep; 49(8):1083-1089. PubMed ID: 32769858
[TBL] [Abstract][Full Text] [Related]
16. Real-world outcomes of FOLFIRINOX vs gemcitabine and nab-paclitaxel in advanced pancreatic cancer: A population-based propensity score-weighted analysis.
Chan KKW; Guo H; Cheng S; Beca JM; Redmond-Misner R; Isaranuwatchai W; Qiao L; Earle C; Berry SR; Biagi JJ; Welch S; Meyers BM; Mittmann N; Coburn N; Arias J; Schwartz D; Dai WF; Gavura S; McLeod R; Kennedy ED
Cancer Med; 2020 Jan; 9(1):160-169. PubMed ID: 31724340
[TBL] [Abstract][Full Text] [Related]
17. The impact of symptom screening on survival among patients with cancer across varying levels of pre-diagnosis psychiatric care.
Sutradhar R; Li Q; Kurdyak P; Barbera L
Cancer Med; 2022 Feb; 11(3):838-846. PubMed ID: 34931479
[TBL] [Abstract][Full Text] [Related]
18. Symptom Evolution in Patients with Esophageal and Gastric Cancer Receiving Palliative Chemotherapy: A Population-Based Study.
Merchant SJ; Kong W; Brundage M; Booth CM
Ann Surg Oncol; 2021 Jan; 28(1):79-87. PubMed ID: 33140252
[TBL] [Abstract][Full Text] [Related]
19. Severe symptoms persist for Up to one year after diagnosis of stage I-III lung cancer: An analysis of province-wide patient reported outcomes.
Hirpara DH; Gupta V; Davis LE; Zhao H; Hallet J; Mahar AL; Sutradhar R; Doherty M; Louie AV; Kidane B; Darling G; Coburn NG
Lung Cancer; 2020 Apr; 142():80-89. PubMed ID: 32120228
[TBL] [Abstract][Full Text] [Related]
20. The association of physical and psychological symptom burden with time to death among palliative cancer outpatients.
Cheung WY; Barmala N; Zarinehbaf S; Rodin G; Le LW; Zimmermann C
J Pain Symptom Manage; 2009 Mar; 37(3):297-304. PubMed ID: 18694634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
